Bifunctional drug could treat tumors resistant to current mTOR inhibitors

2minutemedicine.com

The first known bifunctional inhibitor for the mechanistic target of rapamycin (mTOR) protein was developed to overcome current known mechanisms of tumor resistance to mTOR inhibitors.

Read More